 Vancouver, Canada, Feb. 10, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Neovasc Inc. Neovasc or the Company Nasdaq: NVCN TSX: NVCN announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 36,000,000 common shares at a purchase price of US2.00 per common share in a registered direct offering the Offering priced at-the-market under the Nasdaq Capital Market the Nasdaq rules for aggregate gross proceeds to the Company of approximately US72 million, before deducting placement agents fees and estimated expenses of the Offering payable by the Company. The Offering is expected to close on or about February 12, 2021, subject to customary closing conditions. 